跳至主要内容
临床试验/NCT01244581
NCT01244581已完成3 期

Oral Amoxicillin-clavulanate in Treating Acute Otitis Media in Children: Randomized Double-blind Placebo-controlled Study Including Daily Monitoring With Tympanometry

University of Oulu2 个研究点 分布在 1 个国家目标入组 84 人开始时间: 1999年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
84
试验地点
2
主要终点
Time (days) to disappearance of middle ear effusion

研究概览

简要总结

The purpose of the study is to assess the efficacy of amoxicillin-clavulanate in treating acute otitis media in children. The primary end point is time to disappearance of middle ear effusion which monitored by daily tympanometry performed by families and study physicians.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children with acute otitis media

排除标准

  • Amoxicillin allergy
  • Tympanic membrane perforation
  • Tympanostomy tubes (current)
  • Complication of acute otitis media such as mastoiditis

研究组 & 干预措施

Amoxicillin-clavulanate

Experimental

Oral amoxicillin-clavulanate 40 mg/kg/day divided in two daily doses for 7 days

干预措施: Amoxicillin-clavulanate (Drug)

Placebo

Placebo Comparator

干预措施: Amoxicillin-clavulanate (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Time (days) to disappearance of middle ear effusion

时间窗: Within 60 days

Disappearance of middle ear effusion is defined as the first day of receiving a normal tympanogram (A-curve) in tympanometry.

次要结局

  • Time (days) to disappearance of pain(Within 60 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Terhi Tapiainen

M.D., Ph.D.

University of Oulu

研究点 (2)

Loading locations...

相似试验